SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Progress Mannatech Q3 2023 Earnings Modest Profitability Amid Limited Disclosures Kalaris Therapeutics Inc KLRS Q1 2026 Earnings NarrowerthanExpected Loss Highlights Disciplined Spending OCUL Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage PAGS Q1 2026 Earnings EPS Slightly Misses Estimates Amidst Mixed Market Reaction Ooma Inc OOMA Edges Higher with 132 Gain Testing Key Resistance at 2008 EMCOR Group EME Rises 17 Resistance Test Looms as Momentum Builds Boston Omaha Corporation BOC Advances 162 as Stock Approaches Key Resistance Gran Tierra Energy GTE Slips 34 as Oil Price Headwinds Weigh on Shares SPRU Q1 2026 Earnings EPS Loss of 016 Per Share No Revenue Disclosed